Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("EPO")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 166

  • Page / 7
Export

Selection :

  • and

Effect of culture pH on erythropoietin production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0°CSUNG KWAN YOON; SANG LIM CHOI; JI YONG SONG et al.Biotechnology and bioengineering. 2005, Vol 89, Num 3, pp 345-356, issn 0006-3592, 12 p.Article

EPOS/VIRA ― ett unikt SDI-system i Norden = EPOS/VIRA: un service de diffusion sélective de l'information pour les pays nordiquesENANDER, I; ROSSEL, Y.Tidskrift för dokumentation. 1984, Vol 40, Num 4, pp 121-126, issn 0040-6872Article

Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patientsKHARAGJITSINGH, Aantje V; KOREVAAR, Joke C; VANDENBROUCKE, Jan P et al.Kidney international. 2005, Vol 68, Num 3, pp 1215-1222, issn 0085-2538, 8 p.Article

Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cellsELLIOTT, Steve; BUSSE, Leigh; MCCAFFERY, Ian et al.Journal of immunological methods. 2010, Vol 352, Num 1-2, pp 126-139, issn 0022-1759, 14 p.Article

Total Hemoglobin Mass-A New Parameter to Detect Blood Doping?PROMMER, Nicole; SOTTAS, Pierre-Edouard; SCHOCH, Christian et al.Medicine and science in sports and exercise. 2008, Vol 40, Num 12, pp 2112-2118, issn 0195-9131, 7 p.Article

Erythropoietin is Neuroprotective in a Transgenic Mouse Model of Multiple System AtrophyKÖLLENSPERGER, Martin; KRISMER, Florian; PALLUA, Anton et al.Movement disorders. 2011, Vol 26, Num 3, pp 507-515, issn 0885-3185, 9 p.Article

Corrélation entre les polymorphismes dans le gène de l'érythropoïétine et la limite supérieure de l'hématocrite chez les donneurs de sang réguliers = Association between polymorphisms in erythropoietin gene and upper limit haematocrit levels among regular blood donorsKHABOUR, O. F; BANI-AHMAD, M. A; HAMMASH, N. M et al.Transfusion clinique et biologique (Paris). 2012, Vol 19, Num 6, pp 353-357, issn 1246-7820, 5 p.Article

Immunogenicity of therapeutic proteinsSCHELLEKENS, Huub.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 7, pp 1257-1259, issn 0931-0509, 3 p.Article

Gene dopingHAISMA, H. J; DE HON, O.International journal of sports medicine. 2006, Vol 27, Num 4, pp 257-266, issn 0172-4622, 10 p.Article

Rechnergestützte Programm-Generierung aus einer EPOS-Spezifikation = Génération de programme à l'aide d'un ordinateur, d'une spécification EPOS = Computer aided program generation from an EPOS specificationJOHO, E.rtp. Regelungstechnische Praxis. 1984, Vol 26, Num 7, pp 317-322, issn 0340-4730Article

Erythropoietin-Coated ZP-Microneedle Transdermal System: Preclinical Formulation, Stability, and DeliveryPETERS, Elaine E; AMERI, Mahmoud; XIAOMEI WANG et al.Pharmaceutical research. 2012, Vol 29, Num 6, pp 1618-1626, issn 0724-8741, 9 p.Article

Enhancement of Recombinant Human EPO Production and Sialylation in Chinese Hamster Ovary Cells Through Bombyx mori 30Kc19 Gene ExpressionZESONG WANG; JU HYUN PARK; HEE HO PARK et al.Biotechnology and bioengineering. 2011, Vol 108, Num 7, pp 1634-1642, issn 0006-3592, 9 p.Article

Protective Effects of Erythropoietin on Myocardial Infarction in Rats: The Role of AMP-Activated Protein Kinase Signaling PathwayLI, Xiu-Jiang; WANG, Xiao-Wen; DU, Yu-Jun et al.The American journal of the medical sciences (Print). 2011, Vol 342, Num 2, pp 153-159, issn 0002-9629, 7 p.Article

Cancer cells promote survival through depletion of the von Hippel―Lindau tumor suppressor by protein crosslinkingKIM, D.-S; CHOI, Y.-B; HONG, K.-M et al.Oncogene (Basingstoke). 2011, Vol 30, Num 48, pp 4780-4790, issn 0950-9232, 11 p.Article

Beneficial Hematologic Effects of Daily Oral Ascorbic Acid Therapy in ESRD Patients with Anemia and Abnormal Iron Homeostasis : A Preliminary StudySIROVER, William D; SIDDIQUI, Aqeel A; BENZ, Robert L et al.Renal failure. 2008, Vol 30, Num 9, pp 884-889, issn 0886-022X, 6 p.Article

Erythropoietic response to two epoetin alfa regimens in critically ill patients : A pilot studyDARVEAU, Martin; NOTEBAERT, Eric; DENAULT, André Y et al.Pharmacotherapy. 2006, Vol 26, Num 11, pp 1587-1594, issn 0277-0008, 8 p.Article

Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietinSIREN, Anna-Leena; RADYUSHKIN, Konstantin; PRICE, Jack et al.Brain. 2006, Vol 129, pp 480-489, issn 0006-8950, 10 p., 2Article

Prescriptions licites et illicites par le médecin chez le sportif : Prescriptions illicites = Legal and illegal medical prescriptions for athletesGUILLAUME, G.Journal de traumatologie du sport. 2006, Vol 23, Num 3, pp 186-192, issn 0762-915X, 7 p.Article

Enhancement of recombinant protein production in chinese hamster ovary cells through anti-apoptosis engineering using 30Kc6 geneSHIN SIK CHOI; WON JONG RHEE; EUN JEONG KIM et al.Biotechnology and bioengineering. 2006, Vol 95, Num 3, pp 459-467, issn 0006-3592, 9 p.Article

Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS)PISONI, Ronald L; BRAGG-GRESHAM, Jennifer L; HELD, Philip J et al.American journal of kidney diseases. 2004, Vol 44, Num 1, pp 94-111, issn 0272-6386, 18 p.Article

Biosimilaires actuellement disponibles en hémato-oncologie Partie 1: ASEs (agents stimulant l'érythropoïèse) : Les Biosimilaires = Presently available biosimilars in hematology-oncology ― Part I: ESAs : BiosimilarsKAMIONER, D; DICATO, M.Oncologie (Paris). 2011, Vol 13, Num 5, pp 209-212, issn 1292-3818, 4 p.Article

Effects of High intensity Exercise on Isoelectric Profiles and SDS-PAGE Mobility of ErythropoietinVOSS, S; LÜDKE, A; ROMBERG, S et al.International journal of sports medicine. 2010, Vol 31, Num 6, pp 367-371, issn 0172-4622, 5 p.Article

Self-dissolving microneedles for the percutaneous absorption of EPO in miceITO, Yukako; YOSHIMITSU, Jun-Ichiro; SHIROYAMA, Keiji et al.Journal of drug targeting. 2006, Vol 14, Num 5, pp 255-261, issn 1061-186X, 7 p.Article

Application of a reversible immortalization system for the generation of proliferation-controlled cell linesMAY, Tobias; LINDENMAIER, Werner; WIRTH, Dagmar et al.Cytotechnology (Dordrecht). 2004, Vol 46, Num 2-3, pp 69-78, issn 0920-9069, 10 p.Article

Occupational asthma due to EPO 60LAMBOURN, E. M; HAYES, J. P; MCALLISTER, W. A. C et al.British journal of industrial medicine. 1992, Vol 49, Num 4, pp 294-295, issn 0007-1072Article

  • Page / 7